Phase 2 Bacterial Infections Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 2Phase 3
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Phase 2
Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV
Gram Negative PneumoniaGram-Negative Bacterial InfectionsBacteremia Caused by Gram-Negative Bacteria
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation234 enrolled2 locationsNCT06135350